Uitgebreid zoeken

Bernhard Wardin currently works for Siemens AG as the Head of Technology & Innovation.

Bernhard Scheifele is een Duitse zakenman die aan het hoofd heeft gestaan van 10 verschillende ondernemingen en thans de functie bekleedt van voorzitter van de raad van commissarissen van PHOENIX Pharma SE, voorzitter van de raad van commissarissen van Verlagsgruppe Georg von Holtzbrinck GmbH en co-directeur van Georg von Holtzbrinck Lenkungs GmbH. Dr. Scheifele is tevens lid van de raad van bestuur van 9 andere ondernemingen. In het verleden bekleedde Bernhard Scheifele de functie van voorzitter van de raad van commissarissen van Lavatec AG, voorzitter van de raad van bestuur van HeidelbergCement AG, voorzitter van de raad van toezicht van Tamro Oyj, voorzitter van de raad van toezicht van PHOENIX Pharmahandel GmbH & Co. KG, voorzitter PHOENIX Medical Supplies Ltd., voorzitter raad van commissarissen Brocacef Groep NV, voorzitter raad van commissarissen Phoenix AG (Mannheim) en bestuurder bij Gleiss Lutz Hootz Hirsch PartmbB Rechtsanwlte, Steuerberater. Bernhard Scheifele is afgestudeerd aan de Universiteit van Illinois, aan de Universiteit van Dijon en aan de Universiteit van Freiburg.

De heer Olivier Bernhard is uitvoerend bestuurder bij On Holding AG. Hij maakt deel uit van de Raad van Bestuur van On Holding AG.

Bernhard Pellens is currently the Chairman-Supervisory Board at thyssenkrupp Presta Mülheim GmbH.
He is also a Member-Supervisory Board at Borussia Dortmund GmbH & Co. KGaA, a Professor at Ruhr-Universität Bochum, and a Member-Academy of Sciences at the State of North Rhine-Westphalia.
Additionally, he serves as a Member-Supervisory Board at LVM Krankenversicherungs-AG, a Member-Administration Board at AKAFÖ Akademisches Förderungswerk A.ö.R., and a Member-Supervisory Board at thyssenkrupp Elevator Europe Africa GmbH.
Previously, Dr. Pellens held positions such as Member-Supervisory Board at thyssenkrupp AG from 2005 to 2019, Assistant Professor at Ruhr-Universität Bochum from 1988 to 1993, Professor at the University of Münster in 1994, and Professor at Technische Universität Kaiserslautern from 1993 to 1994.
He also served as a Member-Supervisory Board at LVM Pensionsfonds-AG and LVM Lebensversicherungs-AG, and as Vice President & Head-Task Force at Schmalenbach Gesellschaft FR Betriebswirtschaft Ev from 2003 to 2022.
Furthermore, he was a Member-Auditing & Accounting Board at the Institute of Public Auditors from 2010 to 2014 and a Member-Supervisory Board at Baker Tilly GmbH Wirtschaftsprüfungsgesellschaft.
Dr. Pellens completed his undergraduate and graduate studies at Universität zu Köln and obtained a doctorate degree from Ruhr-Universität Bochum.

Bernhard Hodler currently works at Association of Swiss Asset & Wealth Management Banks, as Vice Chairman and International Institute for Management Development, as Member-Foundation Board from 2018.
Mr. Hodler also formerly worked at Bank Julius Bär & Co. AG, as Chief Executive Officer from 2017 to 2019, Julius Bär Gruppe AG, as Chief Executive Officer from 2017 to 2019, Bank Julius Bär & Co. AG (Research Firm), as Chief Executive Officer from 2017 to 2019, GAM Investment Management (Switzerland) AG, as Director in 2009, Swiss Bankers Association, as Director, ifb AG, as Director, Patrimonium Swiss Real Estate Fund, as Director, Union Bank of Switzerland, as Officer in 1984, Credit Suisse Group AG, as Head-European Risk Management from 1994 to 1996, Credit Suisse AG, as Senior Corporate Auditor from 1987 to 1990, Schweizerischer Bankverein, as Head-Risk Management Asia Pacific from 1993 to 1994, Credit Suisse (International) Holding AG, as Senior Corporate Auditor in 1990, UBS UK Properties Ltd., as Head-Risk Control in 1994, and Julius Baer Holding AG, as Member-Executive Board from 2007 to 2009.
Mr. Hodler received his undergraduate degree in 1987 from Hoehere Wirtschafts & Verwaltungsschule.

Bernhard Montag bekleedt de functie van Chief Executive Officer bij Siemens Healthcare GmbH, Chief Executive Officer bij Siemens Healthcare SAS (CO), Chief Executive Officer bij Siemens Healthineers AG en Chief Executive Officer bij Siemens Healthcare Services Ltd. In zijn vorige loopbaan was Dr. Montag Chief Executive Officer-Healthcare bij Siemens AG. Dr. Montag promoveerde aan de Friedrich-Alexander Universiteit van Erlangen-Nürnberg.

Bernhard Merki is een Zwitsers zakenman die aan het roer heeft gestaan van 5 verschillende bedrijven. De heer Merki bekleedt de positie van voorzitter van EMS-Chemie Holding AG. De heer Merki is ook lid van de raad van bestuur van Seewer Holding AG, HSR Hochschule fr Technik Rapperswil, Ferrum AG en RONDO Burgdorf AG. In het verleden bekleedde de heer Merki de functie van voorzitter bij HOCHDORF Holding AG, president van Euromap SAS, chief executive officer bij 4B Fenster AG en chief executive officer bij Netstal-Maschinen AG. De heer Merki behaalde een bachelor diploma aan de School of Engineering van Brugg-Windisch HTL.

Op dit moment is Bernhard Schmitt Chief Financial Officer van DKSH Holding AG. In zijn vorige carrière bekleedde hij de functie van Chief Financial Officer bij Siltronic AG, Head-Controlling bij Wacker-Chemie sro en Vice President-Central Services bij DKSH (Thailand) Ltd. De heer Schmitt behaalde een MBA aan de Universiteit van Mannheim.

Dr. Bernhard Gnther is Chief Financial Officer bij Fortum Oyj, Onafhankelijk Lid-Raad van Commissarissen bij Uniper SE en Chief Financial & Human Resources bij innogy SE. Hij zetelt in de Raad van Bestuur van Uniper SE, ThyssenKrupp AG en RWE IT GmbH. Dr. Gnther was voorheen werkzaam als Chief Financial Officer & Managing Director bij RWE Supply & Trading GmbH, als Chief Financial Officer & Managing Director bij RWE Trading GmbH, als Chief Financial Officer & Managing Director bij Rwe Gas Midstream Gmbh, als Vice President-Corporate Planning & Controlling bij RWE Power AG, als Chief Financial Officer bij RWE AG, als Project Manager bij McKinsey & Co. (Verenigd Koninkrijk), lid van de raad van commissarissen van Essent NV, lid van de raad van commissarissen van innogy Netze Deutschland GmbH, lid van de raad van commissarissen van RWE Generation SE, en voorzitter van de raad van commissarissen van RWE Pensionsfonds AG. Hij was ook lid van de raad van bestuur van het Deutsches Aktieninstitut eV. Hij is afgestudeerd aan de Universiteit van Oxford en gepromoveerd aan de Universiteit van St. Gallen.

Bernhard Straub bekleedt de functie van voorzitter voor Bosch Ltd.

Bernhard Spalt is Chief Executive Officer voor Erste Group Bank AG en lid van de raad van bestuur van 6 andere ondernemingen. Voordien bekleedde hij de functie van Chief Risk Officer van Erste Group Bank AG Lid-Raad van Toezicht bij Cesk sporitelna as, Chief Risk Officer bij Erste Bank Hungary Zrt. Director & Chief Risk Officer bij Slovensk sporitelna AS en Hoofd-Secretariaat bij Erste Group Bank AG (Verenigde Staten) (allen dochterondernemingen van Erste Group Bank AG). Bernhard Spalt is afgestudeerd aan de Universiteit van Wenen en heeft een doctorstitel behaald aan de Universiteit van Wenen.

Bernhard Scheuble served as the Chairman-Executive Board at Merck KGaA from 2000 to 2005.
He then worked as an Independent Director at Solvay SA from 2006 to 2013.
He also served as a Director at E.
Merck KG and SolVin SA. Dr. Scheuble received his graduate and doctorate degrees from the University of Freiburg.

Mr. Bernhard Telgmann is a President-Technology & Chief Technical Officer at Suzlon Energy Ltd. Mr. Telgmann was previously employed as an EVP-Product & Technology by Senvion GmbH.

De heer Volker Bernhard Dostmann is Chief Financial Officer bij SFS Group AG en mede-directeur bij Kistler Beteiligungsgesellschaft mbH.

Kris Wardin currently works as a Director at Michigan Milk Producers Association.

Philippe de Traux de Wardin currently holds multiple Chairman and Director positions in various companies including Coviphama Co. Ltd., Socfin Research, Camseeds SA, and Financière du Champ de Mars SA. He also serves as a Director for Plantations des Terres Rouges SA, Palmboomen Cultuur Maatschappij Mopoli NV, PT Socfin Indonesia, Liberian Agricultural Co., Socfin KCD, SAFA Cameroun SA, Société Camerounaise de Palmeraies SA, Palmeraies du Cameroun, Société des Palmeraies de la Ferme Suisse SA, Société Anonyme Forestière et Agricole, Brabanta, Induservices SA, Sud Comoe Caoutchouc, Bereby-Finances (Befin) SA, Socfin Agricultural Co. Ltd., Salala Rubber Corp., Plantations Socfinaf Ghana Ltd., Socfin Green Energy, and Socfinco FR SA. In the past, he held positions as an Independent Director for Société Industrielle et Financière de l'Artois SA, Director for Socfinasia SA, Secretary & Executive Director for Société Financière des Caoutchoucs SA, Director for Socfinaf SA, and Non-Executive Director for The Okomu Oil Palm Co. Plc.

Mr Maeder graduated from the University of St. Gallen with a Masters degree in Economics and is a Certified Financial Analyst.
He started his career as a portfolio manager for European equities 1992 for an institution in Liechtenstein, and after a time as market maker for European options and futures in Zug, joined Credit Suisse in 1996 as a European equity portfolio manager.

Mr. Bernhard W.
Langer, CFA, is a Chief Investment Officer at Invesco Asset Management Deutschland GmbH.
He is on the Board of Directors at UMT United Mobility Technology AG.
In this role, he is responsible for Invesco's quantitative investment approach, related products and clients.
Mr. Langer joined Invesco in 1994 as an Equity Portfolio Manager.
He became head of equities in 1996 and Chief Investment Officer for Germany in 2000.
In 2002, he took over the responsibility for the Quantitative Strategies Group (International).
Mr. Langer began his investment career in 1989 with Bayerische Vereinsbank.
He moved to the company's asset management function and led its strategy team from 1992 until his departure.
Mr. Langer earned an MA degree with a focus on economics and banking from the University of Munich.
He is a Chartered Financial Analyst (CFA) charterholder.

Jim Bernhard is a Founder and Partner of Bernhard Capital Partners.
He serves as Chairman of the Investment Committee, serves on the Portfolio Committee and is involved in all areas of the firm’s investment activities.
Prior to founding Bernhard Capital, Jim started The Shaw Group in 1987 with a small personal investment and grew the company into one of the leading global energy services firms with over $6 billion in revenue and 25,000 employees.
For over 25 years, Jim led the growth of The Shaw Group as the CEO, President and Chairman of the Board.
Jim played a leading role in every major decision of the company from its founding until its sale.
Under his stewardship, Shaw became one of the fastest growing companies in the Fortune 500, offering a broad range of engineering, construction, equipment, environmental, and manufacturing services across the energy spectrum.
The Shaw Group became an industry leader in the power industry, a top environmental services provider and the global leader in nuclear power services.
Jim is regarded as an expert in the energy services industry and has testified before the U.S.
Senate’s Energy Subcommittee to discuss pending energy issues in the U.S.
and across the globe.
Jim has served on numerous boards of trade and civic organizations and is very active in his community.
In 2001, Jim was recognized as “U.S.
Entrepreneur of the Year” and in 2009, he and his wife, Dana, founded “Every Kid a King,” a foundation to help children have better opportunities for education and healthcare.
Jim received his B.A. in Construction Management from Louisiana State University.
Previous Board Activity: Chairman of the Board of Bernhard, LLC Chairman of the Board of Epic Piping

Bernhard Schreier is a former Chairman of Linotype-Hell AG and former Chairman of Heidelberg Graphic Equipment Ltd. He also served as Chairman of Heidelberg USA, Inc. and Heidelberg Americas, Inc. Additionally, he was Chairman of the Supervisory Board at Heidelberger Druckmaschinen Vertrieb Deutschland GmbH and a Member of the Supervisory Board at Gerling-Konzern Allgemeine Versicherungs AG.
He was also the Chief Human Resources Officer at Heidelberger Druckmaschinen AG and a Member of the Supervisory Board at Bilfinger SE.
He served as the Chief Operating Officer at Heidelberg Digital LLC and was a Member of the Management Board at Gallus Holding AG.
Currently, he is a Member of the Supervisory Board at ABB AG.

Bernhard Krieg's former jobs include being a Managing Director at Brookfield Public Securities Group LLC from 2006 to 2024, a Vice President at Security Capital Group, Inc., an Analyst at K.
G.
Redding & Associates LLC from 2006 to 2007, and an Analyst at Brookfield Redding LLC from 2006 to 2009.
He holds an MBA from Texas A&M University and an undergraduate degree from Technische Universität München.

Bernhard M.
Wylie is currently a member of the American Association of Professional Landmen, Inc and the Canadian Association of Professional Landmen.
He was a non-independent director at Paramount Resources Ltd. from 2012 to 2015.
He received his undergraduate degree from the University of California, Berkeley.

Bernhard Goepelt worked as the Chief Legal Counsel, Senior VP & General Counsel at The Coca-Cola Co. from 2012 to 2020.
Prior to that, he worked at The Coca-Cola Co. from 1992 to an unknown date.
He was also a member of the German Bar Association.

Dr. Bernhard Mittemeyer, MD, is Independent Director at Hemobiotech, Inc. and a Professor-Urological Surgery at Texas Tech University Health Sciences Center.
He is on the Board of Directors at Hemobiotech, Inc. He received his doctorate degree from Temple University (Pennsylvania).

Bernhard Müllinger worked as a Director-Inhalation Technology at Vectura GmbH and as a Principal at Asklepios International GmbH and Inamed GmbH.
He also worked as a Principal at Helmholtz-Zentrum Berlin für Materialien und Energie GmbH from 1995 to 1998.
Mr. Müllinger received his undergraduate degree from Technische Universität München in 1995.

Bernhard Opitz is currently the Executive Vice President at Cody Laboratories, Inc. He previously worked as an Independent Director at DS Healthcare Group, Inc., Senior Vice President-Engineering at Bayer AG, Vice President-Manufacturing at Nanosphere, Inc., Senior Vice President-Operations at Unilife Corp., Vice President-Operations at Wells Enterprises, Inc. (Iowa), and Senior Vice President-Operations at Unilife Medical Solutions Pty Ltd. He also worked as the Senior Vice President-Operations at Ikonisys, Inc. from 2000 to 2002.
Mr. Opitz received his undergraduate and graduate degrees from Graz University of Technology.

Bernhard Schmitt currently works at LLB Asset Management AG, as Head of Equity & Multi Manager Management.

Bernhard Erich Alois Fischer is currently the Chief Executive Officer at E.ON Generation GmbH and also holds the position of Chief Technology Officer at E.ON Energie AG.
Previously, he worked as the Chairman-Supervisory Board at PreussenElektra GmbH, a Non-Executive Director at URENCO Ltd., and as a Managing Director at Uniper Kraftwerke GmbH.
Fischer received his undergraduate degree from the University of Hannover and his doctorate from Ludwig-Maximilians-Universität München in 2009.

Bernhard Hampl is currently a Director at Chemwerth, Inc., Azalea TopCo, Inc., Solaris Pharma Corp., Softbox (Topco) Ltd., and President of BKH Pharma-Services.
He previously served as President & Chief Executive Officer at Eon Labs, Inc. from 1995 to 2005, President & Chief Executive Officer at Sandoz, Inc. in 2008, Executive Chairman at Fresenius Kabi Pharmaceuticals Holding LLC from 2009 to 2011, and held various other positions at Cytovance Biologics, Inc., APP Pharmaceuticals, Inc., Softbox Systems Ltd., Cambrex Corp., Durachemie GmbH, SiO2 Medical Products, Inc., and Great Point Partners LLC.
He is also a Member-Executive Board at the Association for Accessible Medicines.
Hampl received his undergraduate and doctorate degrees from Ludwig-Maximilians-Universität München.

Mr. Bernhard joined Cascadia Capital as a Managing Director in January 2008.
He came to Cascadia from Stoel Rives, a Portland-based law firm, where he was the founder and Managing Director of the Energy Ventures Group, a member of the Technology Ventures Group and Chairman of the Solar Group.
At Stoel, Mr. Bernhard focused on securities and general corporate law, with particular emphasis on providing counsel to entrepreneurs, investors, technology transfer organizations and others involved with creating, operating, and financing emerging businesses in the Pacific Northwest.
Prior to joining Stoel Rives in 2004, Mr. Bernhard was the Co-Founder and Managing Partner of Cascadia Pacific Management, one of the Pacific Northwest's first early-stage venture capitalists.
He managed four separate institutionally-backed venture funds in Oregon, Washington, and Western Canada, which financed over 100 of the region's fastest growing technology companies, including: Radisys, FEI Company, Creative Multimedia, Antivirals, Sapient Health Network/WebMD, PrintPaks, Templex Technologies, Serveron Corporation and Westport Innovations.
A recipient of The Portland Business Journal's "40 Under 40" Award, given to the most accomplished, influential and civic-minded young executives in Portland, Mr. Bernhard was also a New York-based strategic consultant in the Information Technologies Group of Booz Allen Hamilton.
Mr. Bernhard, who is based in Portland for Cascadia, received his J.D.
from Willamette University College of Law and his B.A., magna cum laude, in economics from Princeton University.

Wolfgang Bernhard currently works at Beijing Benz Automotive Co., Ltd., as Director, AMAG Austria Metall AG, as Member-Supervisory Board from 2019, Andritz AG, as Independent Member-Supervisory Board from 2020, and Österreichische Beteiligungs AG, as Member-Supervisory Board.
Dr. Bernhard also formerly worked at European Automobile Manufacturers Association, as Chairman, Mercedes-Benz South Africa Ltd., as Director, Daimler India Commercial Vehicles Pvt Ltd., as Director, Volkswagen AG, as Member-Supervisory Board from 2005 to 2007, Mercedes-Benz Group AG, as Member-Management Board from 2011 to 2017, and Mercedes-AMG GmbH, as Head-Mercedes Benz Vans Division in 2010.
Dr. Bernhard received his Masters Business Admin degree in 1988 from The Trustees of Columbia University in The City of New York, graduate degree in 1986 from Technische Universität Darmstadt, undergraduate degree in 1984 from Technische Universität Darmstadt, and doctorate degree in 1990 from Johann Wolfgang Goethe-Universität Frankfurt am Main.

Bernhard Biehler formerly worked at Metzler Asset Management GmbH, as Portfolio Manager.

Bernhard A. Sabel is the founder of Braingames Online GmbH and NovaVision, Inc. He holds a doctorate degree from Clark University.

Bernhard Sixt was the founder of Agendia NV, founded in 2003, where he held the title of Chief Executive Officer.
He was also the founder of Agendia, Inc., founded in 2003, where he held the title of Chief Executive Officer from 2010 to 2011.
Currently, he is the Chairman & Chief Executive Officer of ImmunID SAS since 2013 and the Chief Executive Officer of Edinburgh Molecular Imaging Ltd. since 2018.
In the past, he worked as the Director-Global Strategic Marketing Oncology at GE Healthcare Buchler GmbH & Co. KG and as a Principal at Nycomed GmbH.
Dr. Sixt holds a doctorate degree from Technische Universität München and a graduate degree from Ludwig-Maximilians-Universität München.

Bernhard Chwatal is currently the First Vice Chairman-Supervisory Board at Kontron AG since 2013.
He is also the Managing Director & Owner at CableRunner International since 2008, the Managing Director & Owner at Global Health Biotech since 2009, and the Owner of B. Chwatal Beratungs-Und Beteiligungs Gesellschaft mbH since 2004.
In his former positions, Mr. Chwatal served as the Chief Executive Officer of Waagner-Biro AG and Waagner-Biro Bridge Systems AG from 2018 to 2021.
He was also the Chief Executive Officer of CEE Clean Economic Energy AG from 2006 to 2010, and the Managing Director of Automic Holding GmbH from 2012 to 2014.
Additionally, he held the position of Managing Director at UC4 Holding GmbH.
Mr. Chwatal was a Member-Management Board at Libro Handelsgesellschaft mbH from 2001 to 2002, and a Member-Executive Board at Ankerbrot AG from 2003 to 2006.

Bernhard Wolfer worked as a Department Director at Bayerische Landesbank in 2003 and was a Member-Supervisory Board at BBI Bürgerliches Brauhaus Immobilien AG.

Bernhard E.
Boser is Chief Scientific Officer of SiTime Corp.
Previously, he was Member of Technical Staff in the Adaptive Systems Department, AT&T Bell Laboratories from 1988 to 1992.
Mr. Boser holds 6 Patents.
He served as Director of the Berkeley Sensor and Actuator Center in the University of California, Berkeley.
Mr. Boser received a Diploma in Electrical Engineering from the Swiss Federal Institute of Technology, Zurich, in 1984 and an MS in 1985 and PhD from Stanford University in 1988.

Bernhard Schmidt is currently the Chairman & Founding Partner at Shorelight Partners LLP since 2012.
He is also the Chairman-Supervisory Board at Strohm BV and the Chairman at Ryco Energy Solutions, Inc. In the past, he served as an Independent Director at BOURBON Maritime SASU from 2014 to 2016.
He was also the Manager-Strategic Planning at Honeywell International, Inc. from 1991 to 2001 and worked as a Principal at Shell International Gas from 1985 to 1990.
Additionally, he was a Member-Management Board at Wintershall Dea GmbH from 2001 to 2009.
Mr. Schmidt holds an MBA from INSEAD, which he obtained in 1991, and an undergraduate degree from Montanuniversität Leoben, which he received in 1985.

Bernhard Koepp's career history includes current positions as the Chief Executive Officer at Cyrus J.
Lawrence LLC since 2015, and as the Chairman at New Germany Fund, Inc., The Central & Eastern Europe Fund, Inc., and The European Equity Fund, Inc. since 2022.
In his former roles, he worked as the Director-Asset Management Products Group at Deutsche Bank Securities, Inc. from 1993 to 1999, as the Senior Managing Director & Portfolio Manager at International Strategy & Investment, Inc. from 1999 to 2015, as the Senior Managing Director at ISI Group, Inc. from 1999 to 2014, and as a Principal at Deutsche Bank Investment Management, Inc. from 1989 to 1998.
Mr. Koepp obtained his undergraduate degree from George Mason University in 1987 and his graduate degree from The Johns Hopkins University in 1989.

Bernhard Fischer currently works as a Chief Legal Officer at Baerlocher GmbH.

Bernhard Kolb worked as the Head of Human Resources at OneSpan, Inc. He graduated from the University of St. Gallen and the University of Bern.

Bernhard Visker is currently the Director-Supervisory Board at HGA Real Estate GmbH, Co-Managing Director at B & L Hamburg Berlin Bauträger GmbH, Managing Director at Plastogaz SA, and Managing Director at B & L Kreuzstraße Düsseldorf Hotel GmbH.
Previously, he was the Chairman-Supervisory Board at LB Immo Invest GmbH, Principal at Hamburgische Landesbank Girozentrale, and Member-Management Board at Hamburg Commercial Bank AG from 2007 to 2011.
He holds an MBA from The University of Wales.

Bernhard Mohr has headed the newly founded Evonik Venture Capital unit since 2012.
He has more than 20 years of professional experience in venture capital financing and the chemical industry.
Before joining Evonik in 1996, he held various positions at BASF Group in Germany and Spain.
Bernhard Mohr is active in various specialist and supervisory bodies and has advised on IPOs and M&A transactions.
After studying chemistry in Stuttgart and Cincinnati, he obtained his doctorate at the Max Planck Institute for Polymer Research in Mainz.
He then spent research periods in Japan, the USA and France, where he worked with the later Nobel Prize winners Robert Grubbs and Jean-Pierre Sauvage.

Mr. Bernhard Schmid joined the XAnge team in 2008, where he manages the operations in the german-speaking countries.
Bernhard Schmid strengthens DVC’s tech team as partner as of March 2004.
He brings ten years of experience in information and communication technology to the activities of the internationally renowned venture capital company.
Prior to joining DVC he was (from 1999 up until 2004) partner and technology expert at the venture capital company Innotech GmbH.
From 1994 to 1999 he worked as an investment manager for Atlas Venture, a globally active venture capital company, where he was in charge of investments as well as portfolio and exit management for information and communication technology companies.
He holds a degree in business administration from the Ludwig Maximilians University in Munich.
Bernhard is a member of the supervisory board of the following companies: Delticom AG ICIDO GmbH Innominate Security Technology AG KLOTZ DIGITAL AG Sigma-C AG

Bernhard Heiker currently works at Remondis Consulting GmbH, as Co-Managing Director, REMONDIS SE & Co. KG, as Member-Management Board, Mark-E Aktiengesellschaft, as Member-Supervisory Board, and Südwestfalen Energie und Wasser AG, as Member-Supervisory Board.

Dennis F.
Bernhard is currently the Chief Executive Officer at Tenth Power Technologies, Inc. He was previously the Lead Director at Tenth Power Technologies Corp.
from 2012 to 2013.
Prior to that, he worked as the Director & Vice President-Business Development at Neotel International, Inc.

Bernhard Fleischer has a current job as a member of the supervisory board at AVL List GmbH.

Dr. Bernhard Nick is Head-Strategic Planning & Controlling Division at BASF SE.
He received his doctorate degree from Eberhard Karls Universität Tübingen.

Bernhard Kirschbaum's current job(s) include being the Chairman at OMEICOS Therapeutics GmbH, an Independent Non-Executive Director at Redx Pharma Plc, a Director at BioMedx Group, Inc., a Scientific Advisor at FutuRx Ltd., a Member-Supervisory Board at BioMed X GmbH, and a Member-Supervisory Board at Amarna Therapeutics BV since 2019.
Dr. Kirschbaum's former job(s) include being the Chairman-Supervisory Board at Protagen AG, a Research Director at Merck Serono SA from 2005 to 2012, a Director at Enlivex Therapeutics Ltd., a Director at KAHR Medical Ltd., an Independent Director at Enlivex Therapeutics Ltd., a Principal at Institut Pasteur, a Principal at The Rockefeller University, and a Vice President-Discovery Research at Sanofi-Aventis Deutschland GmbH.
Dr. Kirschbaum obtained a doctorate degree from Universität Konstanz in 1989.

Bernhard Iseli has been Managing Director of REMP AG since July 2005.
Prior to his current position at REMP, he was Chief Operating Officer from 2002 to 2005.
He was Project Manager of Telephony for Gfeller AG from 1981 to 1985, Operation Manager of Studer AG from 1992 to 1997, Head of Osteosynthesis Production for Mathys AG from 1997 to 1999, and Managing Director of Mikron Comp-Tec AG from 1999 to 2002.
Previously, he held various senior management positions at Ascom AG from 1981 to 1991.
Mr. Iseli received a degree in Mechanical Engineering from the Berne University of Applied Sciences and holds an MBA.